T

he latest dustup over the rising price of insulin has found its way to a federal court, where several consumers are accusing the three biggest manufacturers — Sanofi, Eli Lilly, and Novo Nordisk — of running a coordinated scheme that has caused patients economic harm.

The lawsuit arrives two months after Senator Bernie Sanders (D-Vt.) and Representative Elijah Cummings (D-Md.) asked the Department of Justice and the Federal Trade Commission to investigate the companies for price collusion. They cited a pattern in which prices for insulin often rose in tandem over several years and expressed concern the drug makers conspired to raise prices and, as a result, drove up the cost for patients and taxpayers.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I BEG my Doctor for samples or expired samples as I am unable to afford the Co-Pays on my Prescriptions now. $900.00 per month equals $10,800.00 per year, could you really do this, it would help to cut down on the population for sure. This would be one SUICIDE, I am sure Christ would not consider to be a SIN !!!!!

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.